Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sonoscape Medical Corp. currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to a distinct examiner within 1 distinct art unit. This represents a highly focused and singular prosecution effort. The applicant can dedicate resources to addressing the specific concerns raised in this single matter without the need to coordinate across multiple pending files. Success in this case will determine the immediate growth of the portfolio.
NYROBI I CELESTINE is the busiest examiner for the portfolio, managing the 1 pending office action. Because there is only one action in the portfolio, this examiner holds total responsibility for the company's current results. The presence of 1 distinct art unit ensures that the administrative procedural requirements remain consistent throughout the prosecution process. This allows for a streamlined approach to patent acquisition within the Medical Devices & Mechanical Engineering field.
The lack of other pending actions means that the applicant can focus entirely on the relationship with NYROBI I CELESTINE. Practitioners should ensure that the arguments presented in the Medical Devices & Mechanical Engineering area are robust, as there are no other concurrent applications to provide alternative paths to allowance. The singular focus of this portfolio simplifies the management of deadlines and examiner communications. This concentrated effort allows for a clear and direct path toward potential patent issuance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18879278 | ULTRASOUND CONTRAST IMAGING METHOD, APPARATUS, SYSTEM AND DEVICE, AND STORAGE MEDIUM | CELESTINE, NYROBI I | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18879278 | ULTRASOUND CONTRAST IMAGING METHOD, APPARATUS, SYSTEM AND DEVICE, AND STORAGE MEDIUM | CELESTINE, NYROBI I | — |
| Art Unit | Apps |
|---|---|
| 3798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18879278 | ULTRASOUND CONTRAST IMAGING METHOD, APPARATUS, SYSTEM AND DEVICE, AND STORAGE MEDIUM | CELESTINE, NYROBI I | 3798 | §103§112 | Non-Final OA | — | Pending | Dec 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSonoscape Medical Corp. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Nyrobi I Celestine has the most, with 1 of Sonoscape Medical Corp.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
